Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase
Summary
MBX Biosciences targets endocrine and metabolic disorders with novel peptide therapies, advancing candidates across several clinical phases.
Description
MBX Biosciences targets endocrine and metabolic disorders with novel peptide therapies, advancing candidates across several clinical phases.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source